Immune protein for respiratory infections in older adults
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether an immune defense protein can help reduce upper respiratory infections (like colds) in people aged 60 and older. It may be a good fit if you get colds or flu-like symptoms several times each season.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You get cold symptoms (like coughing, sneezing, congestion) at least 2-3 times during cold and flu season.
- You can read and understand English, and use a smartphone to download the study app (Chloe by People Science).
- You live in the United States and can have study product shipped to you.
- You are not currently taking strong immune-suppressing medications or treatments (like chemotherapy, high-dose steroids, or biologics), and do not have certain conditions (like HIV/AIDS, leukemia, or organ transplant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.